Thomas Forbes

Analytical Validation and Application of a Targeted Next-Generation Sequencing Mutation-Detection Assay for Use in Treatment Assignment in the NCI-MPACT Trial

Chih-Jian Lih, David Sims, Robin Harrington et al. · Journal of Molecular Diagnostics · 2015 · 45 citations · Full text

Mutation-based Testing, Oncology, Analytical Validation +10

The Papaver Self-Incompatibility Pollen S-Determinant, PrpS, Functions in Arabidopsis thaliana

Barend H. J. de Graaf, Sabina Vatovec, Javier Andrés Juárez‐Díaz et al. · Current Biology · 2011 · 43 citations · Full text

Multiplex isothermal helicase-dependent amplification assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae

Victoria Doseeva, Thomas Forbes, John S. Wolff et al. · Diagnostic Microbiology and Infectious Disease · 2011 · 37 citations

Pathogen Detection, Chlamydia Trachomatis, Diagnostic Test +10

Plasmid-Based Materials as Multiplex Quality Controls and Calibrators for Clinical Next-Generation Sequencing Assays

David Sims, Robin Harrington, Eric C. Polley et al. · Journal of Molecular Diagnostics · 2016 · 28 citations · Full text

Dna Sequencing, Multiplex Technology, Nucleic Acid Biomarkers +9

Validation of ctDNA Quality Control Materials Through a Precompetitive Collaboration of the Foundation for the National Institutes of Health

P. Mickey Williams, Thomas Forbes, Steven P. Lund et al. · JCO Precision Oncology · 2021 · 20 citations · Full text